Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma Meeting Abstract
| Authors: | Postow, M. A.; Knox, S. J.; Goldman, D.; Panageas, K.; Halpenny, D.; McCabe, D.; Macri, M. J.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; Venhaus, R. R.; Barker, C. A. |
| Abstract Title: | Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 501s |
| Language: | English |
| ACCESSION: | WOS:000442916003324 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9550 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9550 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
